Qingyong Ma

No ORCID on file · 1 paper in corpus
lab-animal 2021
iScience ·doi:10.1016/j.isci.2021.103400

Emerging evidence suggests that ADP-ribosylation factor like-4c (Arl4c) may be a potential choice for cancer treatment. However, its role in pancreatic cancer, especially in tumor-stroma interactions and drug resistance, is still unknown. I…